Birdwatch Note
2024-11-14 08:47:27 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Les souris utilisées en laboratoire permettent d'élaborer des vaccins pour lutter contre des cancers humains. https://www.bfmtv.com/sante/un-vaccin-contre-le-cancer-teste-avec-succes-sur-des-souris_AN-201802080035.html Taxer les laboratoires aura donc un coût supplémentaire sur le prix des vaccins, et par effet domino, sur le budget de la Sécurité Sociale ou les patients concernés.
Written by C3EBB1FE519C89218935E9C90CF816108CEE7F4ABE7C44D5502C765CC1819237
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1854953759266271429
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1856982265428926911
- noteId - 1856982265428926911
- participantId -
- noteAuthorParticipantId - C3EBB1FE519C89218935E9C90CF816108CEE7F4ABE7C44D5502C765CC1819237 Participant Details
- createdAtMillis - 1731574047797
- tweetId - 1854953759266271429
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Les souris utilisées en laboratoire permettent d'élaborer des vaccins pour lutter contre des cancers humains. https://www.bfmtv.com/sante/un-vaccin-contre-le-cancer-teste-avec-succes-sur-des-souris_AN-201802080035.html Taxer les laboratoires aura donc un coût supplémentaire sur le prix des vaccins, et par effet domino, sur le budget de la Sécurité Sociale ou les patients concernés.
Note Ratings
rated at | rated by | |
2024-11-14 18:27:06 -0600 | Rating Details | |
2024-11-14 17:39:48 -0600 | Rating Details | |
2024-11-14 16:04:13 -0600 | Rating Details | |
2024-11-14 15:44:45 -0600 | Rating Details | |
2024-11-14 15:08:45 -0600 | Rating Details | |
2024-11-14 14:25:14 -0600 | Rating Details | |
2024-11-14 13:10:17 -0600 | Rating Details | |
2024-11-14 12:50:29 -0600 | Rating Details | |
2024-11-14 12:06:08 -0600 | Rating Details | |
2024-11-14 11:46:09 -0600 | Rating Details | |
2024-11-14 11:34:23 -0600 | Rating Details | |
2024-11-14 10:38:34 -0600 | Rating Details | |
2024-11-14 10:09:48 -0600 | Rating Details | |
2024-11-14 08:29:49 -0600 | Rating Details | |
2024-11-14 07:52:59 -0600 | Rating Details | |
2024-11-14 07:47:39 -0600 | Rating Details | |
2024-11-14 07:29:06 -0600 | Rating Details | |
2024-11-14 07:13:49 -0600 | Rating Details | |
2024-11-14 07:13:12 -0600 | Rating Details | |
2024-11-14 06:58:49 -0600 | Rating Details | |
2024-11-14 06:55:01 -0600 | Rating Details | |
2024-11-14 06:51:49 -0600 | Rating Details | |
2024-11-14 06:51:41 -0600 | Rating Details | |
2024-11-14 06:46:01 -0600 | Rating Details | |
2024-11-14 06:43:31 -0600 | Rating Details | |
2024-11-14 06:39:36 -0600 | Rating Details | |
2024-11-14 06:23:06 -0600 | Rating Details | |
2024-11-14 06:22:43 -0600 | Rating Details | |
2024-11-14 06:19:12 -0600 | Rating Details | |
2024-11-14 06:11:58 -0600 | Rating Details | |
2024-11-14 06:08:32 -0600 | Rating Details | |
2024-11-14 06:01:45 -0600 | Rating Details | |
2024-11-14 05:46:51 -0600 | Rating Details | |
2024-11-14 05:42:12 -0600 | Rating Details | |
2024-11-14 05:31:52 -0600 | Rating Details | |
2024-11-14 04:35:07 -0600 | Rating Details | |
2024-11-14 04:18:15 -0600 | Rating Details | |
2024-11-14 03:40:00 -0600 | Rating Details | |
2024-11-14 03:09:19 -0600 | Rating Details | |
2024-11-16 12:22:08 -0600 | Rating Details | |
2024-11-15 14:38:19 -0600 | Rating Details | |
2024-11-15 12:34:27 -0600 | Rating Details | |
2024-11-15 12:04:12 -0600 | Rating Details | |
2024-11-15 08:13:27 -0600 | Rating Details | |
2024-11-15 07:22:15 -0600 | Rating Details | |
2024-11-15 02:47:59 -0600 | Rating Details | |
2024-11-15 02:28:02 -0600 | Rating Details | |
2024-11-15 01:26:19 -0600 | Rating Details | |
2024-11-15 01:13:09 -0600 | Rating Details | |
2024-11-15 00:27:39 -0600 | Rating Details | |
2024-11-15 10:26:26 -0600 | Rating Details | |
2024-11-15 05:13:20 -0600 | Rating Details | |
2024-11-15 02:16:44 -0600 | Rating Details | |
2024-11-15 01:41:02 -0600 | Rating Details | |
2024-11-15 00:50:01 -0600 | Rating Details | |
2024-11-14 23:55:36 -0600 | Rating Details | |
2024-11-14 17:05:48 -0600 | Rating Details | |
2024-11-14 15:58:30 -0600 | Rating Details | |
2024-11-14 14:56:53 -0600 | Rating Details | |
2024-11-14 10:02:11 -0600 | Rating Details | |
2024-11-14 09:37:37 -0600 | Rating Details | |
2024-11-14 08:20:27 -0600 | Rating Details | |
2024-11-14 07:24:16 -0600 | Rating Details | |
2024-11-14 07:01:19 -0600 | Rating Details | |
2024-11-14 06:48:56 -0600 | Rating Details | |
2024-11-14 06:43:17 -0600 | Rating Details | |
2024-11-14 06:19:38 -0600 | Rating Details | |
2024-11-14 06:09:04 -0600 | Rating Details | |
2024-11-14 04:50:50 -0600 | Rating Details | |
2024-11-14 04:43:50 -0600 | Rating Details |